Skip to main content

mHeath based Diabetes Management in India - Remote monitoring Tools

In the past we have read a lot of research projects that determine the outcomes based overview of Diabetes management and the use of remote monitoring tools. We have spoken to Doctors,  technologists as well as equipment manufacturers and all of these available tools represent a breakthrough for clinician/patient communication to enhance disease management and improve health outcomes.

However, for India we were yet to find out the drivers, challenges, consumer behaviour, expected adoption level and value add to the end users. Here is a recent study undertaken by HealthCursor Consulting Group India to understand the DM market better.

SURVEY questionnaire:

1. If you are given a Glucometer (blood sugar check machine) for free, will you check your blood sugar daily ?
1)      Yes
2)      No

2. Your mobile phone will automatically send this data to your Doctor. Your Doctor will then SMS, EMAIL or call you if your sugar is not in control. How much you will you easily pay for this service? (Note: the doctor will not disturb you in case of normal readings.)
1)      Rs 1000-2000/month
2)      Rs 500-900/month
3)      Rs 100-400/month

3. Will you feel more comfortable if you do not have to do your blood sugar monitoring yourself but a nurse sitting in a nearby chemist store/pharmacy does it for you? In this case you will have to step out of your house but will this give you more confidence?
1)      Yes, I will feel better if a nurse does that and I don't mind driving to the chemist store.
2)      No, I would like to do it at home myself

4. Are you using a Glucometer already? Would you mind buying a new Glucometer if that connects with your phone and transfers your data automatically to the doctor?
1)      Yes, I have a Glucometer and Yes, I will buy a new one if it is the same price as my old one but has advance features like what is mentioned above.
2)      Yes, I have a Glucometer and No, I don't want a new Glucometer.
3)      No, I don't have a Glucometer but Yes, I will buy a new one if it is the same price as the one available in the market but has advance features like what is mentioned above
4)      No, I don't have a Glucometer but I will only buy known conventional brands Glucometer and will not trust any advance ones.

5. What all a Diabetic should invest in?
1)      Glucometer
2)      Glucometer, Doctor Consultation
3)      Glucometer, Doctor Consultation, Daily Glucose monitoring and advice
4)      Glucometer, Doctor Consultation,Daily Glucose monitoring and advice, Diagnostic checkups
5)      Glucometer, Doctor Consultation, Daily Glucose monitoring and advice, Diagnostic checkups, Diet plan, Exercise plan, Lifestyle and wellness plan

SAMPLE: Volunteers from the following companies participated in this survey.

Popular posts from this blog

AI and Deep learning for Cervical Cancer

Worldwide, the cancer of the cervix (lower portion of the uterus) is the fourth most common cancer. It is also one of the most common causes of deaths due to cancer in women.

Most of my patients that participated in my public health project had wither dementia, Alzheimer's or were frail and sometimes immobile. They would forget their surroundings, spouse name and even getting a regular medical checkup was a challenge. These women, when asked to go for cervical cancer diagnosis, opted out and never showed up. Most of these tests are widely available but are uncomfortable and invasive. Patients are also not keen to go for them unless indicated.

1 in 5 cancer patients across the world experience delay in diagnosis and, it holds true for cervical cancer as well. Cervical cancer is diagnosed more frequently at more advanced stages.

The human papillomavirus (HPV) infection is responsible for 90 percent cases. However, all women infected with this virus will not develop cervical cancer. …

Royal Society of Medicine elected Dr Ruchi Dass Fellow

Popular Health Technology Author and Founder, HealthCursor Consulting Group Dr. Ruchi V Dass elected Royal Society of Medicine Honorary Fellow in the United Kingdom. (Photo courtesy of Ruchi Dass)

Joining some of the elite names among scientists and physicians, Health Technology Author and Business Icon Ruchi Dass has been elected as a fellow of The Royal Society of Medicine in the United Kingdom.

Dass is a renowned Physician and has worked with development organisation across the world driving technology driven public health initiatives. She is the Founder of the consulting group HealthCursor, and Author of several journals, including her upcoming book on “Big Data in Healthcare” with Springer.

Dr Dass wrote a book on “Innovations in Healthcare” that was unveiled by the Honourable President of India Mr. Pranab Mukherjee in 2013. Dr. Ruchi Dass was listed amongst Most Powerful and Influential leaders in IT by Information week in 2013 and also received INTEROP’s “Women leader” recogni…

The Formula of Driver and Demand- Indian Startups story

The healthcare industry is currently experiencing change at an unprecedented rate. Change is not only occurring in the technology used in diagnostics and care delivery, but this change is so fundamental that it could, and likely will, fundamentally alter the business model of the industry.
Today we have fitness bands, healthcare apps, appointment schedulers, health chats and several such means to access healthcare but one thing that all of this does not necessarily correlate with high quality of care or better outcomes. We need to understand that “Not even a Ferrari will get us to our destination without a driver.”Formula of Driver:
Driver = (Need + Incentive) where;
Incentive = (Value + Reward) Need = (Gap + Demand)
To define the best drivers, we need to first address the need. Need might not make economic or business sense but it is the best opportunity to leave an impact. No one remembers how much business a “Mughal-e-Azam” or “Usual suspects” did but everyone remembers that these were…